Increasing prevalence of Neisseria gonorrhoeae with decreased susceptibility to ceftriaxone and resistance to azithromycin in Hangzhou, China (2015–17)
Author(s) -
Jing Yan,
Juan Xue,
Yan Chen,
Shi Chen,
Qiang Wang,
Chuanling Zhang,
Shenghai Wu,
Huoyang Lv,
Yunsong Yu,
Stijn van der Veen
Publication year - 2018
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dky412
Subject(s) - ceftriaxone , neisseria gonorrhoeae , azithromycin , microbiology and biotechnology , medicine , gonorrhea , neisseriaceae , china , antibiotics , biology , virology , geography , archaeology , human immunodeficiency virus (hiv)
Development of resistance in Neisseria gonorrhoeae to ceftriaxone monotherapy or ceftriaxone plus azithromycin dual therapy is a global public health concern. The aim of this study was to analyse the trend in antimicrobial resistance in Hangzhou, China, over the period 2015-17.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom